JXL069

JXL069

AOB14546B

CAS: 2260696-63-5

 

Chemical Name: (E)-3-(1-(3,5-Bis(trifluoromethyl)benzyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-2-cyanoacrylic acid

More details

961 Items

$95.00

$95.00 per 100 mg

Quantity Discount Table - Order More To Get More Price Discount

Quantity100 mgUnit Price ($/mg or $/Unit)Final Price
15 $80.75 Total: $403.75
110 $68.40 Total: $684.00
125 $57.95 Total: $1,448.75
150 $49.40 Total: $2,470.00
1100 $42.75 Total: $4,275.00

Overview

Novel potent mitochondrial pyruvate carrier (MPC) inhibitor to treat hair loss

Functional Overview of JXL069

1. Potent and Selective Inhibition of Mitochondrial Pyruvate Carrier (MPC)

JXL069 is a highly selective and effective inhibitor of the mitochondrial pyruvate carrier (MPC), which plays a critical role in transporting pyruvate—the key product of glycolysis—into the mitochondria. By inhibiting MPC, JXL069 blocks this mitochondrial entry, redirecting cellular metabolism toward glycolysis.Wikipedia

2. Inhibitory Potency (IC₅₀ Values)

  • Reports an IC₅₀ value of 42.8 nM for JXL069 as an MPC inhibitor.

  • In other biochemical assays, particularly involving MPC1/2-mediated pyruvate transport, the IC₅₀ is approximately 0.53 µM.

3. Metabolic and Biological Effects

  • Metabolic Shift: By hindering pyruvate import, JXL069 forces cells to rely more on glycolysis instead of mitochondrial oxidative phosphorylation.World Mitochondria Society

  • Hair Follicle Stem Cell Activation: This metabolic switch is biologically significant in hair biology—JXL069 stimulates dormant hair follicle stem cells (in the telogen phase) to re-enter the active growth phase (anagen), enhancing hair growth in preclinical models.WikipediaWorld Mitochondria Society

4. Therapeutic Research Applications

  • Hair Loss (Alopecia): Originally developed at the University of California, JXL069 is being investigated for androgenetic alopecia. Related compounds, including a candidate named PP405, are now in Phase II clinical trials as topical scalp treatments.Wikipedia

  • Oncology and Metabolic Disease Research: MPC inhibitors like JXL069 are also valuable for studying cancer metabolism and metabolic disorders, offering potential therapeutic avenues in these areas.World Mitochondria Society

5. Structure–Activity Relationship (SAR) Insights

  • JXL069 features a 7-azaindole heterocycle, and SAR studies show it exhibits stronger MPC inhibition than related analogues containing 4- or 6-azaindole cores or traditional indole cores like JXL020.PMCUCLA Chemistry

Chemical Properties

Molecular FormulaC20H21F6N3O2
Molecular Weight439.32
CAS Numbers2260696-63-5
SolubilityDMSO
Purity98% by HPLC
IUPAC/Chemical Name (E)-3-(1-(3,5-Bis(trifluoromethyl)benzyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-2-cyanoacrylic acid
InChl KeyIGVIZFSCSSEYDA-WUXMJOGZSA-N
InChl CodeInChI=1S/C20H11F6N3O2/c21-19(22,23)14-4-11(5-15(7-14)20(24,25)26)9-29-10-13(6-12(8-27)18(30)31)16-2-1-3-28-17(16)29/h1-7,10H,9H2,(H,30,31)/b12-6+
SMILES CodeFC(C1=CC(C(F)(F)F)=CC(CN2C=C(/C=C(C(O)=O)C#N)C3=CC=CN=C32)=C1)(F)F

Storage and Handling

0°C (short term), -20°C (long term), desiccated

Synonyms

JXL 069; JXL-069

References

1) Xiaoguang Liu et al., Development of Novel Mitochondrial Pyruvate Carrier Inhibitors to Treat Hair Loss, J. Med. Chem. 2021, 64, 4, 2046–2063